“Medicare Drug Committees Lack COI Oversight”

By Ed Silverman // March 7th, 2013 // 12:18 pm-Pharmalot
“Here is yet another sobering dispatch about a conflicts of interest that affects prescription drugs. A new report finds that pharmacy and therapeutic committees that make formulary coverage decisions for Medicare Part D plans have limited oversight of conflicts held by committee members. As a result, the insurers lack the ability to prevent financial interests from influencing coverage decisions.”

This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s